CEO Jeff Galvin Believes We Can

What if developers of cell and gene therapies treated their products like software releases? What if the human body could be manipulated like a highly complex computer?

Jeff Galvin, CEO of American Gene Technologies, certainly has that mindset, frequently referring to cell and gene therapies as “reprogramming the human computer.”